Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04395391 · ClinicalTrials.gov registry record

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

A clinical trial of COVID-19, sponsored by Exact Sciences Corporation.

Completed
Registry status
30
Enrollment target
1
Study location

NCT04395391 is a study of COVID-19 that has completed, run by Exact Sciences Corporation. The registered enrollment target is 30 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04395391, a study of COVID-19, has completed, sponsored by Exact Sciences Corporation.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to determine the usability of the SARS-CoV-2 Specimen Collection Materials for at-home collection and mailing of sample to the testing laboratory.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST SARS-CoV-2

Study Locations (1)

Wisconsin

  • Exact Sciences - Madison

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-05-18
Est. Completion 2020-06-16

Sponsor

Exact Sciences Corporation

30 total trials

What the Registry Record Tells You About NCT04395391

The ClinicalTrials.gov registry entry for NCT04395391 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which SARS-CoV-2 is the first listed.

NCT04395391 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04395391 about?

NCT04395391 is a clinical study titled "Home Usability Study of the SARS-CoV-2 (COVID-19) Test". The primary objective is to determine the usability of the SARS-CoV-2 Specimen Collection Materials for at-home collection and mailing of sample to the testing laboratory.

What is the current status of trial NCT04395391?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-05-18. Estimated completion is 2020-06-16.

What conditions does trial NCT04395391 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04395391?

The interventions under investigation include: SARS-CoV-2 (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04395391?

This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04395391 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.